RA0637

antibody from Oursmab

Targeting: ROR1 NTRKR1

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0637

Provider

Oursmab

Product name

Zilovertamab (Biosimilar Reference Antibody) (ROR1)

Antibody type

Monoclonal

Description

Zilovertamab (formerly Cirmtuzumab; UC-961) is an investigational humanized monoclonal antibody that targets the Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1). It is being developed for the treatment of ROR1-expressing hematologic malignancies and solid tumors, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), aiming to block Wnt signaling and induce tumor cell death.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Zilovertamab (Biosimilar Reference Antibody) (ROR1)-RA0637-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Zilovertamab (Biosimilar Reference Antibody) (ROR1)-RA0637 in a linear range of 15.63¨C125 ng/mL.